Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

The Clinicopathologic Features of Molecular Apocrine Breast Cancer

´ëÇѺ´¸®ÇÐȸÁö 2012³â 46±Ç 2È£ p.169 ~ 176
Â÷À±Áø, Á¤¿ìÈñ, ±¸ÀÚ½Â,
¼Ò¼Ó »ó¼¼Á¤º¸
Â÷À±Áø ( Cha Yoon-Jin ) 
Yonsei University Health System Department of Pathology

Á¤¿ìÈñ ( Jung Woo-Hee ) 
Yonsei University College of Medicine Department of Pathology
±¸Àڽ ( Koo Ja-Seung ) 
Yonsei University College of Medicine Department of Pathology

Abstract


Background : To elucidate the clinicopathologic features and their implications on the immunohistochemistry in cases of molecular apocrine breast cancer (MABC).

Methods : Immunohistochemical (IHC) staining for estrogen receptor (ER), human epidermal growth factor receptor 2 (HER-2), cytokeratin (CK) 5/6, epidermal growth factor receptor (EGFR), androgen receptor (AR), gamma-glutamyltrasferase 1 (GGT1) and Ki-67 was performed on tissue microarray breast cancer samples from 204 patients. Phenotypes of breast cancer were divided based on the IHC status of ER, AR and GGT1 into the following: luminal type, ER positive and AR and/or GGT1 positive; basal type, ER, AR, and GGT1 negative; non-basal type, ER positive and AR and GGT1 negative; and MABC type, ER negative and AR and/or GGT1 positive.

Results : In our series of patients (n=204), there were 26 cases of MABC. Besides, there were 18, 60, and 100 cases of luminal type, basal type and non-basal type, respectively. The MABC demonstrated apocrine histology and a higher prevalence of HER-2 positivity than other phenotypes. With the basal type, the MABC manifested a more frequent expression of CK5/6 and EGFR and a higher Ki-67 index than other phenotypes (p<0.001). There were no significant differences in patient prognosis between the phenotypes of breast cancer.

Conclusions : MABC are distinguishable from other phenotypes based on the apocrine histology and a higher expression rate of HER-2.

Å°¿öµå

Breast neoplasms; Molecular apocrine; Immunohistochemistry

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS